BiotechTube

Prucalopride + Placebo

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Constipation

Conditions

Constipation

Trial Timeline

May 1, 2010 → Mar 1, 2011

NCT ID
NCT01116206

About Prucalopride + Placebo

Prucalopride + Placebo is a phase 3 stage product being developed by Johnson & Johnson for Constipation. The current trial status is completed. This product is registered under clinical trial identifier NCT01116206. Target conditions include Constipation.

What happened to similar drugs?

20 of 20 similar drugs in Constipation were approved

Approved (20) Terminated (5) Active (0)
✅Naldemedine + PlaceboShionogiApproved
✅Polyethylene Glycol 3350 + MovantikAstraZenecaApproved
✅MOVANTIK™ (naloxegol) + Sugar PillAstraZenecaApproved
✅Alvimopan + PlaceboMerckApproved
✅Tegaserod and Polyethylene Glycol 3350NovartisApproved
✅TegaserodNovartisApproved
✅Tegaserod and PlaceboNovartisApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01116206Phase 3Completed

Competing Products

20 competing products in Constipation

See all competitors
ProductCompanyStageHype Score
Lubiprostone + Lubiprostone + PlaceboDr. Reddy's LaboratoriesPhase 3
37
YH12852 IR 0.05mg + YH12852 IR 0.1mg + YH12852 IR 0.3mg + YH12852 IR 0.5mg + YH12852 IR 1mg + YH12852 IR 2mg + YH12852 IR 3mg + YH12852 DR1 0.5mg + YH12852 DR1 1mg + YH12852 DR1 2mg + YH12852 DR1 4mg + YH12852 DR2 8mg + Prucalopride 2mg + PlaceboYuhanPhase 1/2
32
linaclotide + placeboAstellas PharmaPhase 2
35
linaclotide + PlaceboAstellas PharmaPhase 3
40
ASP0456 + PlaceboAstellas PharmaPhase 2
35
linaclotide + PlaceboAstellas PharmaPhase 3
40
linaclotideAstellas PharmaPre-clinical
26
Naldemedine + PlaceboShionogiPhase 3
40
Naldemedine + PlaceboShionogiApproved
50
NaldemedineShionogiPhase 1/2
39
Naldemedine + PlaceboShionogiPhase 3
40
Placebo + NaldemedineShionogiPhase 2
35
Naldemedine + PlaceboShionogiPhase 3
40
AJG555EisaiPhase 3
40
NaloxegolKyowa KirinPre-clinical
26
NaloxegolKyowa KirinPhase 1
29
naloxegol + non-PAMORA laxativeKyowa KirinPre-clinical
18
NaloxegolKyowa KirinPre-clinical
26
NaloxegolKyowa KirinPre-clinical
26
Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers) + Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers)AbbViePhase 3
40